Related Experiment Video

Updated: Mar 12, 2026

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR
08:30

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR

Published on: May 16, 2012

25.1K

MicroRNA-424 impairs ubiquitination to activate STAT3 and promote prostate tumor progression

Cecilia Dallavalle, Domenico Albino, Gianluca Civenni

    The Journal of Clinical Investigation
    |November 8, 2016
    PubMed

    Insights

    MicroRNA miR-424 upregulation impairs protein degradation in prostate cancer by targeting COP1, leading to oncogenic transcription factor STAT3 activation. Blocking miR-424 offers a potential therapeutic strategy for ESE3/EHF-deficient tumors.

    Area of Science:

    • Molecular Biology
    • Oncology
    • Biochemistry

    Background:

    • Ubiquitin ligase complex mutations alter protein turnover, driving tumorigenesis.
    • Prostate cancer involves complex regulatory pathways affecting cell growth and survival.

    Purpose of the Study:

    • To investigate an alternative mechanism of tumorigenesis involving microRNA deregulation in prostate cancer.
    • To identify the role of miR-424 in regulating protein turnover and its impact on oncogenic pathways.

    Main Methods:

    • Analysis of microRNA and protein expression in prostate cancer cells.
    • Target validation assays to confirm interactions between miR-424, COP1, and STAT3.
    • Functional studies assessing the impact of miR-424 modulation on cancer cell properties.

    Main Results:

    • Upregulation of miR-424 impairs ubiquitination and degradation of oncogenic transcription factors.
    • miR-424 targets the E3 ubiquitin ligase COP1, leading to STAT3 accumulation and activation.
    • Loss of ESE3/EHF initiates the miR-424/COP1/STAT3 axis deregulation.
    • Blocking miR-424 reverts COP1 silencing and STAT3 activation.

    Conclusions:

    • miR-424 acts as an oncogenic effector by promoting noncanonical STAT3 activation in prostate cancer.
    • The miR-424/COP1/STAT3 axis is a critical node in ESE3/EHF-deficient tumorigenesis.
    • Targeting miR-424 presents a potential therapeutic strategy for specific prostate cancer subtypes.

    More Related Videos

    miRNA Expression Analyses in Prostate Cancer Clinical Tissues11:29

    miRNA Expression Analyses in Prostate Cancer Clinical Tissues

    Published on: September 8, 2015

    11.3K
    Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome07:23

    Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

    Published on: June 15, 2016

    9.0K

    Related Concept Videos

    MicroRNAs01:22

    MicroRNAs

    MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
    24.5K
    MicroRNAs01:22

    MicroRNAs

    MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
    4.2K
    mTOR Signaling and Cancer Progression03:03

    mTOR Signaling and Cancer Progression

    The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
    The mTOR pathway or the...
    5.0K
    PI3K/mTOR/AKT Signaling Pathway01:22

    PI3K/mTOR/AKT Signaling Pathway

    The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
    6.1K
    Abnormal Proliferation02:23

    Abnormal Proliferation

    Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
    5.4K
    Receptor Downregulation in MVBs01:15

    Receptor Downregulation in MVBs

    Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
    The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
    2.9K